Xiang J, Sun X. Socioeconomic disparities in HPV vaccine uptake: multivariable analysis of vaccination data from Tianjin (2018-2023).
Front Public Health 2025;
13:1428267. [PMID:
40084203 PMCID:
PMC11903397 DOI:
10.3389/fpubh.2025.1428267]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2024] [Accepted: 02/17/2025] [Indexed: 03/16/2025] Open
Abstract
Objectives
As the first socio-demographic profiling of HPV vaccines in Chinese cities, this study assesses equity implications through compositional analysis of covered populations, with multilevel examination of vaccine-type selection determinants.
Method
Utilizing HPV vaccination data obtained from the Jinnan Center for Disease Control and Prevention (CDC) spanning from 2018 to 2023, we conducted a retrospective analysis. Hierarchical logistic regression was employed to model the joint effects of age, ethnicity, occupation, and urban-rural residence on vaccination behaviors. Vaccine type preference was categorized as bivalent, quadrivalent, or nonavalent.
Result
Three key disparities were revealed in the analysis. Age-stratified access revealed the highest proportion of recipients among women aged 33-38 years (29.6%) and 39-44 years (21.9%), contrasting with less than 1% participation in the 9-14 year-old cohort. Educationally, 87.3% held at least a bachelor's degree, compared to 12.7% with below-college education (χ 2 = 6048.89, p < 0.001). Clear urban-rural divide, with 99.7% of recipients in urban areas and just 0.3% in rural areas (χ 2 = 76.79, p < 0.001). Vaccine-type selection showed socioeconomic patterns, with nonavalent vaccines preferred by urban professionals (OR = 1.577, 95% CI: 1.16-2.142) and those with incomes above 5000 yuan (OR = 1.958, 95% CI: 0.26-3.527).
Conclusion
Demonstrating Hart's Inverse Care Law, Tianjin's program disproportionately immunizes socioeconomically secure urbanites. We propose: (1) school-based mandates for pre-sexual debut cohorts; (2) rural vaccination-social insurance integration; (3) domestic 9-valent vaccine development with needs-based subsidies. These evidence-based reforms are critical for achieving equitable 90% coverage by 2030.
Collapse